Relapsing Catastrophic Antiphospholipid Syndrome Potential Role of Microangiopathic Hemolytic Anemia in Disease Relapses11This article is devoted to the memory of Ronald A. Asherson, who died while preparing this manuscript.

Seminars in Arthritis and Rheumatism

Volumn 42, Issue 4, 2013, Pages 417-423

  Espinosa, Gerard ^a   Rodríguez Pintó, Ignasi ^a   Gomez Puerta, José A ^a   Pons Estel, Guillermo ^a   Cervera, Ricard ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; RITUXIMAB; STEROID;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HEART; HUMAN; INFECTION; KIDNEY; LABORATORY TEST; LUNG; MALE; MORTALITY; PLASMAPHERESIS; PRIORITY JOURNAL; REGISTER; RELAPSE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

ADULT; AGED; ANEMIA, HEMOLYTIC; ANTIPHOSPHOLIPID SYNDROME; CATASTROPHIC ILLNESS; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE;

EID: 84873739334     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2012.05.005     Document Type: Article

References (23)

1. Ruiz-Irastorza G., Crowther M., Branch W., Khamashta M.A. Antiphospholipid syndrome. Lancet 2010, 376:1498-1509.
2. Asherson R.A., Cervera R., de Groot P.G., Erkan D., Boffa M.C., Piette J.C., et al. Catastrophic antiphospholipid syndrome: International consensus statement on classification criteria and treatment guidelines. Lupus 2003, 12:530-534.
3. Bucciarelli S., Espinosa G., Cervera R., Erkan D., Gómez-Puerta J.A., Ramos-Casals M., et al. Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum 2006, 54:2568-2576.
4. Erkan D., Espinosa G., Cervera R. Catastrophic antiphospholipid syndrome: Updated diagnostic algorithms. Autoimmun Rev 2010, 10:74-79.
5. Erkan D., Asherson R.A., Espinosa G., Cervera R., Font J., Piette J.C., et al. Long term outcome of catastrophic antiphospholipid syndrome survivors. Ann Rheum Dis 2003, 62:530-533.
6. Lämmle B., Kremer Hovinga J.A., Alberio L. Thrombotic thrombocytopenic purpura. J Thromb Haemost 2005, 3:1663-1675.
7. Espinosa G., Bucciarelli S., Cervera R., Lozano M., Reverter J.C., de la Red G., et al. Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis 2004, 63:730-736.
8. Cerveny K.C., Sawitzke A.D. Relapsing catastrophic antiphospholipid antibody syndrome: A mimic for thrombotic thrombocytopenic purpura?. Lupus 1999, 8:477-481.
9. Willis M.S., Bandarenko N. Relapse of thrombotic thrombocytopenic purpura: Is it a continuum of disease?. Semin Thromb Hemost 2005, 31:700-708.
10. Gordon A., McLean C.A., Ryan P., Roberts S.K. Steroid-responsive catastrophic antiphospholipid syndrome. J Gastroenterol Hepatol 2004, 19:479-480.
11. Cervera R., Bucciarelli S., Plasín M.A., Gómez-Puerta J.A., Plaza J., Pons-Estel G., et al. Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of a series of 280 patients from the "CAPS Registry". J Autoimmun 2009, 32:240-245.
12. Ono T., Mimuro J., Madoiwa S., Soejima K., Kashiwakura Y., Ishiwata A., et al. Severe secondary deficiency of von-Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: Its correlation with development of renal failure. Blood 2006, 107:528-534.
13. Porta C., Caporali R., Montecucco C. Autoimmunity in thrombotic thrombocytopenic purpura. Semin Thromb Hemost 2005, 31:633-640.
14. Amoura Z., Costedoat-Chalumeau N., Veyradier A., Wolf M., Ghillani-Dalbin P., Cacoub P., et al. Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in two patients with primary antiphospholipid syndrome. Arthritis Rheum 2004, 50:3260-3264.
15. Díaz-Cremades J., Fernandez-Fuentes F., Ruano J.A., Tapia M., Soler S., Bosch J.M. Concurrent thrombotic thrombocytopenic purpura and antiphospholipid syndrome: a rare and severe clinical combination. Br J Haematol 2009, 147:584-585.
16. de Carvalho J.F., Freitas C.A., Lima I.V., Leite C.C., Lage L.V. Primary antiphospholipid syndrome with thrombotic thrombocytopenic purpura: A very unusual association. Lupus 2009, 18:841-844.
17. Kosaka M., Takahashi N., Saitoh H., Masai R., Ito M., Sato R., et al. Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in a patient with antiphospholipid antibodies and Charcot-Marie-Tooth disease. Intern Med 2011, 50:487-493.
18. Matsuda J., Sanaka T., Gohchi K., Matsui K., Uchida S., Matsumoto M., et al. Occurrence of thrombotic thrombocytopenic purpura in a systemic lupus erythematosus patient with antiphospholipid antibodies in association with a decreased activity of von Willebrand factor-cleaving protease. Lupus 2002, 11:463-464.
19. Mukai M., Ieko M., Atsumi T., Notoya A., Kohno M. Multiple thromboses in major arteries in a patient with antiphospholipid syndrome associated with excess of a large multimer of von Willebrand factor. Lupus 2001, 10:895-896.
20. Murphy J.J., Leach I.H. Findings at necropsy in the heart of a patient with anticardiolipin syndrome. Br Heart J 1989, 62:61-64.
21. Neuwelt C.M., Daikh D.I., Linfoot J.A., Pfister D.A., Young R.G., Webb R.L., et al. Catastrophic antiphospholipid syndrome: Response to repeated plasmapheresis over three years. Arthritis Rheum 1997, 40:1534-1539.
22. Undas A., Swadźba J., Undas R., Musiał J. Three episodes of acute multiorgan failure in a woman with secondary antiphospholipid syndrome. Pol Arch Med Wewn 1998, 100:556-560.
23. Asherson R.A., Espinosa G., Menahem S., Yinh J., Bucciarelli S., Bosch X., et al. Relapsing catastrophic antiphospholipid syndrome: Report of three cases. Semin Arthritis Rheum 2008, 37:366-372.